Literature DB >> 15716630

Nicotine attenuates morphological deficits in a contusion model of spinal cord injury.

R Ravikumar1, Isabella Fugaccia, Stephen W Scheff, James W Geddes, Cidambi Srinivasan, Michal Toborek.   

Abstract

Protection against the progression of secondary injury appears to be an effective therapeutic strategy in spinal cord injury (SCI). Evidence indicates that nicotine can induce potent neuroprotective effects against injury to spinal cord neurons. Therefore, the present study was focused on the effects of nicotine on the behavioral and morphological recovery associated with SCI. Adult male Long-Evans rats were subjected to a moderate contusion model of SCI and received subcutaneous injections of nicotine for 14 days at the dose of 0.35 or 7 mg/kg/day. The rats were examined using the BBB locomotor rating scale for 6 weeks. At the end of the BBB recording, spinal cords were examined for the volumetric tissue sparing of gray and white matters. All SCI rats demonstrated a loss of hindlimb function followed by a recovery phase that peaked at 2-3 weeks after the trauma. Compared to untreated SCI rats, chronic nicotine administration appeared to improve the recovery of the locomotor functions. Indeed, nicotine-treated animals scored consistently higher on the BBB scale indicating that the treatment altered animal behavior. However, when taking under consideration correction factors for multiple comparisons, these data did not reach significance at overall experimental levels of significance 0.05. Nevertheless, nicotine administration was effective in sparing tissue at injury epicenter and a lower dose of nicotine also resulted in significant sparing of white matter of the injured spinal cord. These results suggest that agonists of neuronal nicotinic receptors can be attractive candidates for SCI therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716630     DOI: 10.1089/neu.2005.22.240

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  8 in total

1.  Bone marrow mesenchymal stem cells combined with minocycline improve spinal cord injury in a rat model.

Authors:  Dayong Chen; Wei Zeng; Yunfeng Fu; Meng Gao; Guohua Lv
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Impact of chronic nicotine on sciatic nerve injury in the rat.

Authors:  Kyle Brett; Renée Parker; Shannon Wittenauer; Ken-Ichiro Hayashida; Tracey Young; Michelle Vincler
Journal:  J Neuroimmunol       Date:  2007-03-23       Impact factor: 3.478

3.  Neuroprotective effects of exendin-4 in rat model of spinal cord injury via inhibiting mitochondrial apoptotic pathway.

Authors:  Haotian Li; Zhiqiang Jia; Gang Li; Xingzhang Zhao; Ping Sun; Jiquan Wang; Zhongkai Fan; Gang Lv
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury.

Authors:  Joe E Springer; Ravikumar Rangaswamy Rao; Hyang Ran Lim; Sung Ig Cho; Gyoeng Joon Moon; Hee Young Lee; Eui Jin Park; Jai Sung Noh; Byoung Joo Gwag
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

5.  Neuroprotective effect of apigenin in rats after contusive spinal cord injury.

Authors:  Feng Zhang; Fangcai Li; Gang Chen
Journal:  Neurol Sci       Date:  2013-10-29       Impact factor: 3.307

6.  Wogonoside alleviates inflammation induced by traumatic spinal cord injury by suppressing NF-κB and NLRP3 inflammasome activation.

Authors:  Yonglin Zhu; Hanzhong Zhu; Zhaojie Wang; Fengguang Gao; Jingsheng Wang; Wenqiang Zhang
Journal:  Exp Ther Med       Date:  2017-08-08       Impact factor: 2.447

7.  Chrysin suppressed inflammatory responses and the inducible nitric oxide synthase pathway after spinal cord injury in rats.

Authors:  Yong Jiang; Fu-Liang Gong; Guang-Ben Zhao; Jie Li
Journal:  Int J Mol Sci       Date:  2014-07-10       Impact factor: 5.923

8.  Neuroprotective mechanisms of rutin for spinal cord injury through anti-oxidation and anti-inflammation and inhibition of p38 mitogen activated protein kinase pathway.

Authors:  Hong-Liang Song; Xiang Zhang; Wen-Zhao Wang; Rong-Han Liu; Kai Zhao; Ming-Yuan Liu; Wei-Ming Gong; Bin Ning
Journal:  Neural Regen Res       Date:  2018-01       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.